Cited by 628TGF-β signaling in diseasesCancer Cells and MetastasisKruppel-like factors research

The DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index.

TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice

Open access

Cui, Wei, Fowlis, Deborah J, Bryson, Sheila, Duffie, Elizabeth, Ireland, Hazel, Balmain, Allan, Akhurst, Rosemary J·1996·Cell

DOI 10.1016/s0092-8674(00)80127-0

Open this paper in CoChat — free account Open PDF

Abstract

TGFbeta1 has been implicated in cell cycle control and carcinogenesis. To address the exact function of TGFbeta1 in skin carcinogenesis in vivo, mice with TGFbeta1 expression targeted to keratinocytes were subjected to long-term chemical carcinogenesis treatment. TGFbeta1 showed biphasic action during multistage skin carcinogenesis, acting early as a tumor suppressor but later enhancing the malignant phenotype. The transgenics were more resistant to induction of benign skin tumors than controls, but the malignant conversion rate was vastly increased. There was also a higher incidence of spindle cell carcinomas, which expressed high levels of endogenous TGFbeta3, suggesting that TGFbeta1 elicits an epithelial-mesenchymal transition in vivo and that TGFbeta3 might be involved in maintenance of the spindle cell phenotype. The action of TGFbeta1 in enhancing malignant progression may mimic its proposed function in modulating epithelial cell plasticity during embryonic development.

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)80127-0

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U., Liotta, L. A., Falanga, V., & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,867
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction
Kaartinen, V., Voncken, J. W., Shuler, C. F., Warburton, D., Bu, D., Heisterkamp, N., & Groffen, J. (1995) · Nature Genetics · doi:10.1038/ng1295-415 · Cited by 1,042
TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.
Miettinen, P. J., Ebner, R., Lopez, A. R., & Derynck, R. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.2021 · Cited by 939
Transforming growth factor–β3 is required for secondary palate fusion
Proetzel, G., Pawlowski, S. A., Wiles, M. V., Yin, M., Boivin, G. P., Howles, P. N., Ding, J., Ferguson, M. W. J., & Doetschman, T. (1995) · Nature Genetics · doi:10.1038/ng1295-409 · Cited by 908
Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.
Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., & Berger, W. H. (1987) · PubMed · Cited by 898
Synergistic induction of mesoderm by FGF and TGF-β and the identification of an mRNA coding for FGF in the early xenopus embryo
Kimelman, D., & Kirschner, M. W. (1987) · Cell · doi:10.1016/0092-8674(87)90110-3 · Cited by 872
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1991) · Springer eBooks · doi:10.1007/978-1-4612-3210-0_8 · Cited by 869
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-49295-2_8 · Cited by 744
In situ end‐labelling detects DNA strand breaks in apoptosis and other physiological and pathological states
Ansari, B., Coates, P. J., Greenstein, B., & Hall, P. A. (1993) · The Journal of Pathology · doi:10.1002/path.1711700102 · Cited by 578
Distribution and modulation of the cellular receptor for transforming growth factor-beta.
Wakefield, L. M., Smith, D. M., Masui, T., Harris, C. C., & Sporn, M. B. (1987) · The Journal of Cell Biology · doi:10.1083/jcb.105.2.965 · Cited by 535
Embryonic gene expression patterns of TGF β1, β2 and β3 suggest different developmental functions in vivo
Millan, F. A., Denhez, F., Kondaiah, P., & Akhurst, R. J. (1991) · Development · doi:10.1242/dev.111.1.131 · Cited by 501
Self-citation
Cell death by apoptosis and its protective role against disease
Bursch, W., Oberhammer, F., & Schulte‐Hermann, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90077-j · Cited by 423
A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.
Torre‐Amione, G., Beauchamp, R. D., Koeppen, H., Park, B. H., Schreiber, H. W., Moses, H. L., & Rowley, D. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1486 · Cited by 403
Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.
Welch, D. R., Fabra, À., & Nakajima, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7678 · Cited by 389
Inactivation of the Type II Receptor Reveals Two Receptor Pathways for the Diverse TGF-β Activities
Chen, R., Ebner, R., & Derynck, R. (1993) · Science · doi:10.1126/science.8388126 · Cited by 378
Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes.
Flanders, K. C., Thompson, N. L., Cissel, D. S., Obberghen‐Schilling, E. V., Baker, C. C., Kass, M. E., Ellingsworth, L. R., Roberts, A. B., & Sporn, M. B. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.2.653 · Cited by 370
Transforming growth factor beta and cell cycle regulation.
Alexandrow, M. G., & Moses, H. L. (1995) · PubMed · Cited by 363
Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
Arteaga, C. L., Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., & Forbes, J. T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116871 · Cited by 359
Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.
Gorsch, S. M., Memoli, V. A., Stukel, T. A., Gold, L. I., & Arrick, B. A. (1992) · PubMed · Cited by 343
Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution.
Wakefield, L. M., Winokur, T. S., Hollands, R. S., Christopherson, K. S., Levinson, A. D., & Sporn, M. B. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114932 · Cited by 320
Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells
Sun, L., Wu, G., Willson, J. K. V., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L. E., Wang, X. F., & Brattain, M. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47215-8 · Cited by 319
Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor β
Potts, J. D., & Runyan, R. B. (1989) · Developmental Biology · doi:10.1016/0012-1606(89)90111-5 · Cited by 291
Mammary tumor suppression by transforming growth factor beta 1 transgene expression.
Pierce, D. F., Gorska, A. E., Chytil, A. M., Meise, K. S., Page, D. L., Coffey, R. J., & Moses, H. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4254 · Cited by 291
Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells.
Rotello, R. J., Lieberman, R., Purchio, A. F., & Gerschenson, L. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3412 · Cited by 275
Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.
Anzano, M. A., Roberts, A. B., Meyers, C. A., Komoriya, A., Lamb, L. C., Smith, J. M., & Sporn, M. B. (1982) · PubMed · Cited by 265
Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis
Akhurst, R. J., Fee, F., & Balmaint, A. (1988) · Nature · doi:10.1038/331363a0 · Cited by 265
Self-citation
Differential expression of TGF beta isoforms in murine palatogenesis
FitzPatrick, D. R., Denhez, F., Kondaiah, P., & Akhurst, R. J. (1990) · Development · doi:10.1242/dev.109.3.585 · Cited by 254
Self-citation
Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice.
Sellheyer, K., Bickenbach, J. R., Rothnagel, J. A., Bundman, D. S., Longley, M. A., Krieg, T. M., Roche, N. S., Roberts, A. B., & Roop, D. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5237 · Cited by 254
Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro.
Steiner, M. S., & Barrack, E. R. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.1.1738367 · Cited by 239
TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis
Akhurst, R. J., Lehnert, S. A., Faissner, A., & Duffie, E. (1990) · Development · doi:10.1242/dev.108.4.645 · Cited by 233
Self-citation
Mesoderm induction in Xenopus caused by activation of MAP kinase
Umbhauer, M., Marshall, C. J., Mason, C., Old, R. W., & Smith, J. C. (1995) · Nature · doi:10.1038/376058a0 · Cited by 221
Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells.
Garrigue‐Antar, L., Muñoz-Antonia, T., Antonia, S. J., Gesmonde, J. F., Vellucci, V. F., & Reiss, M. (1995) · PubMed · Cited by 214
Mediation of Wound-Related Rous Sarcoma Virus Tumorigenesis by TGF-β
Sieweke, M. H., Thompson, N. L., Sporn, M. B., & Bissell, M. J. (1990) · Science · doi:10.1126/science.2163544 · Cited by 207
Periosteal osteogenic sarcoma
Unni, K. K., Dahlin, D. C., & Beabout, J. W. (1976) · Cancer · doi:10.1002/1097-0142(197605)37:5 · Cited by 207
Involvement of p21ras in Xenopus mesoderm induction
Whitman, M., & Melton, D. A. (1992) · Nature · doi:10.1038/357252a0 · Cited by 206
Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.
Glick, A. B., Kulkarni, A. B., Tennenbaum, T., Hennings, H., Flanders, K. C., O’Reilly, M. A., Sporn, M. B., Karlsson, S., & Yuspa, S. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6076 · Cited by 206
Transforming growth factor-β switches the pattern of integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin
Heino, J., & Massagué, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88255-6 · Cited by 197
Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene.
Dickson, R. B., Kasid, A., Huff, K. K., Bates, S. E., Knabbe, C., Bronzert, D. A., Gelmann, E. P., & Lippman, M. E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.3.837 · Cited by 194
Differential expression of genes encoding TGFs β1, β2, and β3 during murine palate formation
Pelton, R. W., Hogan, B. L. M., Miller, D. A., & Moses, H. L. (1990) · Developmental Biology · doi:10.1016/0012-1606(90)90401-4 · Cited by 192
In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor beta 1.
Lin, J. K., & Chou, C. (1992) · PubMed · Cited by 188
Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis.
Roop, D. R., Krieg, T. M., Mehrel, T., Cheng, C., & Yuspa, S. H. (1988) · PubMed · Cited by 183
TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.
Wu, S. P., Theodorescu, D., Kerbel, R. S., Willson, J. K. V., Mulder, K. M., Humphrey, L. E., & Brattain, M. G. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.116.1.187 · Cited by 180
Transforming growth factor-β 1 as a signal for induction of cell death by apoptosis
Bursch, W., Oberhammer, F., Jirtle, R. L., Askari, M., Sedivy, R., Grasl‐Kraupp, B., Purchio, A. F., & Schulte‐Hermann, R. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.98 · Cited by 172
Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta.
Am, M., Williams, A. C., Sm, G., & Paraskeva, C. (1991) · PubMed · Cited by 170
Transforming growth factor β stimulates mamary adenocarcinoma cell invasion and metastasis potential
Welch, D. R. (1990) · Medical Entomology and Zoology · Cited by 164
Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1.
Arrick, B. A., Lopez, A. R., Elfman, F., Ebner, R., Damsky, C. H., & Derynck, R. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.118.3.715 · Cited by 157
Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.Preprint
Glick, A. B., Lee, M., Darwiche, N., Kulkarni, A. B., Karlsson, S., & Yuspa, S. H. (1994) · Genes & Development · doi:10.1101/gad.8.20.2429 · Cited by 153
Integrin heterodimer and receptor complexity in avian and mammalian cells.
Hynes, R. O., Marcantonio, E. E., Stepp, M. A., Urry, L. A., & Yee, G. H. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.109.1.409 · Cited by 150
Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma.
Gomella, L. G., Sargent, E. R., Wade, T. P., Anglard, P., Linehan, W. M., & Kasid, A. (1989) · PubMed · Cited by 141
Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.
Arteaga, C. L., Dugger, T. C., Moses, H. L., Hurd, S. D., & Pietenpol, J. A. (1993) · PubMed · Cited by 139
Induction of papillomas with a high probability of conversion to malignancy
Hennings, H., Shores, R., Mitchell, P., Spangler, E. F., & Yuspa, S. H. (1985) · Carcinogenesis · doi:10.1093/carcin/6.11.1607 · Cited by 132
Spindle-cell carcinoma: A case report
Middlehurst, R. J., Blackburn, C., & Sloan, P. (1990) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/0266-4356(90)90136-9 · Cited by 124
Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential.
Jouanneau, J., Gavrilović, J., Caruelle, D., Jaye, M., Moens, G., Caruelle, J. P., & Thiery, J. P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2893 · Cited by 122
Autocrine induction of tumor protease production and invasion by a metallothionein‐regulated TGF‐beta 1 (Ser223, 225).
Samuel, S. K., Hurta, R. A. R., Kondaiah, P., Khalil, N., Turley, E. A., Wright, J., & Greenberg, A. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05205.x · Cited by 119
Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Arteaga, C. L., Coffey, R. J., Dugger, T. C., McCutchen, C. M., Moses, H. L., & Lyons, R. M. (1990) · PubMed · Cited by 116
The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis.
Tennenbaum, T., Weiner, A. K., Belanger, A. J., Glick, A. B., Hennings, H., & Yuspa, S. H. (1993) · PubMed · Cited by 115
Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7.
Buchmann, A., Ruggeri, B., Klein–Szanto, A. J., & Balmain, A. (1991) · PubMed · Cited by 114
Self-citation
Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells.
Chang, H. L., Gillett, N. A., Figari, I. S., Lopez, A. R., Palladino, M. A., & Derynck, R. (1993) · PubMed · Cited by 113
Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene-induced regression of mammary tumors.
Jirtle, R. L., Haag, J. D., Ariazi, E. A., & Gould, M. N. (1993) · PubMed · Cited by 110
Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype.
Caulı́n, C., Scholl, F. G., Frontelo, P., Gamallo, C., & Quintanilla, M. (1995) · PubMed · Cited by 105
Aberrant expression during two‐stage mouse skin carcinogenesis of a type 147‐kDa keratin, k13, normally associated with terminal differentiation of internal stratified epithelia
Nischt, R., Roop, D. R., Mehrel, T., Yuspa, S. H., Rentrop, M., Winter, H., & Schweizer, J. (1988) · Molecular Carcinogenesis · doi:10.1002/mc.2940010205 · Cited by 104
Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice.Preprint
Cui, W., Fowlis, D. J., Cousins, F., Duffie, E., Bryson, S., Balmain, A., & Akhurst, R. J. (1995) · Genes & Development · doi:10.1101/gad.9.8.945 · Cited by 95
Self-citation
Complex patterns of expression suggest extensive roles for the α2β1 integrin in murine development
Wu, J. E., & Santoro, S. A. (1994) · Developmental Dynamics · doi:10.1002/aja.1001990405 · Cited by 90
Keratins as markers of malignancy in mouse epidermal tumors
Winter, H., Schweizer, J., & Goerttler, K. (1980) · Carcinogenesis · doi:10.1093/carcin/1.5.391 · Cited by 86
Carcinosarcoma of the lung. Review of the literature and report of two cases treated by pneumonectomy
Bergmann, M., Ackerman, L. V., & Kemler, L. R. (1951) · Cancer · doi:10.1002/1097-0142(195109)4:5 · Cited by 85
The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event
Stoler, A. B., Stenbäck, F., & Balmain, A. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.5.1103 · Cited by 85
Self-citation
Carcinosarcoma of the lung.
Moore, T. C. (1961) · PubMed · Cited by 85
Expression of β1, β3, β4, and β5 Integrins by Human Lung Carcinoma Cells of Different Histotypes
Falcioni, R., Cimino, L., Gentileschi, M. P., D’Agnano, I., Zupi, G., Kennel, S. J., & Sacchi, A. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1017 · Cited by 84
Stimulatory role of transforming growth factors in multistage skin carcinogenesis: Possible explanation for the tumor‐inducing effect of wounding in initiated nmri mouse skin
Förstenberger, G., Rogers, M., Schnapke, R., Bauer, G., Höufler, P., & Marks, F. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430531 · Cited by 84
Immunolocalisation of epidermal growth factor (EGF), EGF receptor and transforming growth factor alpha (TGFα) during murine palatogenesis in vivo and in vitro
Dixon, M. J., Garner, J., & Ferguson, M. W. J. (1991) · Anatomy and Embryology · doi:10.1007/bf01744264 · Cited by 79
Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: Analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling
Tatebe, S., Ishida, M., Kasagi, N., Tsujitani, S., Kaibara, N., & Ito, H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960117)65:2 · Cited by 75
Self-citation
Role of Oncogenes and Tumor Suppressor Genes in Multistage Carcinogenesis
Yuspa, S. H., Dlugosz, A. A., Cheng, C., Denning, M. F., Tennenbaum, T., Glick, A. B., & Weinberg, W. C. (1994) · Journal of Investigative Dermatology · doi:10.1038/jid.1994.16 · Cited by 73
Discordant transforming growth factor beta 1 RNA and protein localization during chemical carcinogenesis of the skin.
Fowlis, D. J., Flanders, K. C., Duffie, E., Balmain, A., & Akhurst, R. J. (1992) · PubMed · Cited by 73
Self-citation
Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression.
Tennenbaum, T., Yuspa, S. H., Grover, A., CASTRONOVO, V., Sobel, M. E., Yamada, Y., & Luca, L. M. D. (1992) · PubMed · Cited by 73
Lacrimal gland malignant mixed tumors (carcinomas arising in benign mixed tumors): A clinico-pathologic study
Perzin, K. H., Jakobiec, F. A., LiVolsi, V. A., & Desjardins, L. (1980) · Cancer · doi:10.1002/1097-0142(19800515)45:10 · Cited by 71
Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.
Wu, S. P., Sun, L., Willson, J. K. V., Humphrey, L. E., Kerbel, R. S., & Brattain, M. G. (1993) · PubMed · Cited by 71
Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
Dlugosz, A. A., Cheng, C., Williams, E. K., Darwiche, N., Dempsey, P. J., Mann, G. B., Dunn, A. R., Coffey, R. J., & Yuspa, S. H. (1995) · PubMed · Cited by 67
Escape from transforming growth factor beta control and oncogene cooperation in skin tumor development.
Missero, C., y Cajal, S. R., & Dotto, G. P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9613 · Cited by 64
Keratin gene expression in mouse skin tumors and in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate.
Toftgård, R., Yuspa, S. H., & Roop, D. R. (1985) · PubMed · Cited by 63
Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation.
Haddow, S., Fowlis, D. J., Parkinson, K. M., Akhurst, R. J., & Balmain, A. (1991) · PubMed · Cited by 63
Self-citation
Lack of transforming growth factor-beta 1 expression in benign skin tumors of p53null mice is prognostic for a high risk of malignant conversion.
Cui, W., Kemp, C. J., Duffie, E., Balmain, A., & Akhurst, R. J. (1994) · PubMed · Cited by 61
Self-citation
Keratin modifications in epidermis, papillomas, and carcinomas during two-stage carcinogenesis in the SENCAR mouse.
Nelson, K. G., & Slaga, T. J. (1982) · PubMed · Cited by 55
Altered epidermal cell growth control in vivo by inducible expression of transforming growth factor beta 1 in the skin of transgenic mice.
Fowlis, D. J., Cui, W., Johnson, S. A., Balmain, A., & Akhurst, R. J. (1996) · PubMed · Cited by 55
Self-citation
Multistage chemical carcinogenesis protocols produce spindle cell carcinomas of the mouse skin
Klein–Szanto, A. J., Larcher, F., Bonfil, R. D., & Conti, C. J. (1989) · Carcinogenesis · doi:10.1093/carcin/10.11.2169 · Cited by 52
Regulation of human colon‐carcinoma cell adhesion to extracellular matrix by transforming growth factor β1
Chakrabarty, S. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500624 · Cited by 45
TGF‐β1 and skin carcinogenesis: Antiproliferative effect in vitro and TGF‐β1 mRNA expression during epidermal hyperproliferation and multistage tumorigenesis
Krieg, P., Schnapke, R., Fürstenberger, G., Vogt, I., & Marks, F. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040208 · Cited by 45
Autocrine Transforming Growth Factor β1 Modulates the Expression of Integrin α5β1 in Human Colon Carcinoma FET Cells
Wang, D., Zhou, G.-H., Birkenmeier, T. M., Gong, J., Sun, L., & Brattain, M. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.14154 · Cited by 36
Expression of α6β4 integrin increases during malignant conversion of mouse epidermal keratinocytes: Association of β4 subunit to the cytokeratin fraction
Gómez, M., Navarro, P., Quintanilla, M., & Cano, A. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90272-a · Cited by 35
Epidermal growth factor receptor ligands regulate keratin 8 expression in keratinocytes, and transforming growth factor alpha mediates the induction of keratin 8 by the v-rasHa oncogene.
Cheng, C., Tennenbaum, T., Dempsey, P. J., Coffey, R. J., Yuspa, S. H., & Dlugosz, A. (1993) · PubMed · Cited by 34
Changes in response to, and production of, transforming growth factor type β during neoplastic progression in cultured rat tracheal epithelial cells
Terzaghi-Howe, M. (1989) · Carcinogenesis · doi:10.1093/carcin/10.6.973 · Cited by 28
Epithelial cell plasticity in neoplasia.
Jouanneau, J., Gc, T., Boyer, B., Vallés, A. M., & Thiery, J. P. (1991) · PubMed · Cited by 28
Leucine metabolism in patients with malignant disease
Waterhouse, C., & Mason, J. (1981) · Cancer · doi:10.1002/1097-0142(19810815)48:4 · Cited by 26
Transgenic Approaches to the Analysis of ras and p53 Function in Multistage CarcinogenesisPreprint
Kemp, C. J., Burns, P. A., Brown, K., Nagase, H., & Balmain, A. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.048 · Cited by 20
Self-citation
DNA Repair Defect Tied to Mutated TGF-β Receptor Gene
Marx, J. L. (1995) · Science · doi:10.1126/science.7761848 · Cited by 18
Expression of E-cadherin in embryogenetic ingression and cancer invasion
Mareel, M., Bracke, M., Roy, F. M. V., & Vakaet, L. C. (1993) · The International Journal of Developmental Biology · doi:10.1387/ijdb.8507565 · Cited by 18
Adhesion systems in embryonic epithelial-to-mesenchyme transformations and in cancer invasion and metastasis
Vallés, A. M., Boyer, B., & Thiery, J. P. (1991) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-7494-6_2 · Cited by 12

Research works printed but not linked: 11

Arteaga, 1990, Growth stimulation of human breast cancer cells with anti-transforming growth factor β antibodies, Cell Growth Differ., 1, 367
Caulin, 1995, Chronic exposure of cultured transfected mouse epidermal cells to TGFβ1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype, Cell Growth Differ., 6, 1027
Cui, W., and Akhurst, R.J. (1996). Transforming growth factors β: biochemistry and biology in vitro and in vivo. In Growth Factors and Cytokines in Health and Disease, C. Bondy and D. LeRoith, eds. (Greenwich, Connecticut: JAI Press), in press.
Cui, 1994, Lack of TGFβ1 expression in benign skin tumours of p53 null mice is prognostic for a high risk of malignant conversion, Cancer Res., 54, 5831
Dlugosz, 1995, Autocrine transforming growth factor α is dispensible for v-ras-Ha-induced epidermal neoplasia, Cancer Res., 55, 1883
Fowlis, 1992, Discordant TGFβ1 RNA and protein localisations during chemical carcinogenesis of the skin, Cell Growth Differ., 3, 81
Fowlis, 1996, Altered epidermal growth control in vivo in transgenic mice expressing TGFβ1 from an inducible keratin gene promoter, Cell Growth Differ., 7, 679
Gomella, 1989, Expression of transforming growth factor α in normal adult kidney and enhanced expression of transforming growth factors α and β in renal cell carcinoma, Cancer Res., 49, 6972
Manning, 1991, Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β), Oncogene, 6, 1471
Steiner, 1992, Transforming growth factor-β-1 overproduction in prostate cancer, Mol. Endocrinol., 6, 15
Tennenbaum, 1992, Extracellular matrix receptors and mouse skin carcinogenesis, Cancer Res., 52, 2966

Sorted by citations

The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,697
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,453

See all 628

Authors: Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J.
Affiliations: University of Glasgow (GB)
Corresponding author: Akhurst, Rosemary J
ORCID: Cui, Wei
Bryson, Sheila
Balmain, Allan
Akhurst, Rosemary J
Venue: Cell
Publisher: Elsevier BV
Published: 1996-08
Volume: 86
Issue: 4
Pages: 531-542
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/s0092-8674(00)80127-0
OpenAlex: W2026460094
Cited by: 628
References: 98
Citations by year: 2026: 6 · 2025: 4 · 2024: 10 · 2023: 20 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 8 · 2018: 13 · 2017: 12 · 2016: 9 · 2015: 15 · 2014: 22 · 2013: 22 · 2012: 26
FWCI: 7.57
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 6194 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
Keywords: TGF-β1, skin carcinogenesis, sarcomatoid carcinoma, keratinocytes, tumor suppressor, malignant progression, TGF-beta3, epithelial-mesenchymal transition, chemical carcinogenesis, transgenic mice, epithelial cell plasticity
MeSH terms: Animals, Carcinoma, Carcinoma, Squamous Cell, Cells, Cultured, Female, Immunologic Techniques, Keratins, Mice, Transgenic, Papilloma, Skin Neoplasms, Integrins, Transforming Growth Factor beta, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks